Traws Pharma, Inc. (TRAW) Financials

TRAW Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 8.2 million 13.5 million
Dec. 31, 2025 10.6 million 11.2 million
Sept. 30, 2025 12.4 million 7.9 million
June 30, 2025 15.6 million 7.4 million

TRAW Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -2.6 billion 634.0 million
Dec. 31, 2025 -2.8 million 327000
Sept. 30, 2025 -4.0 million 135000
June 30, 2025 -6.0 million 105000

TRAW Net Income

No data available :(

TRAW Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 3.1 million - -
Dec. 31, 2025 3.8 million - -
Sept. 30, 2025 6.4 million - -
June 30, 2025 13.1 million - -

TRAW Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 10.6 million
Dec. 31, 2025 9.1 million
Sept. 30, 2025 8.8 million
June 30, 2025 5.8 million

TRAW Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 2.6 million 4.9 million 2.0 million -
Dec. 31, 2025 - 5.0 million 2.3 million -
Sept. 30, 2025 - 2.3 million 1.7 billion -
June 30, 2025 - 2.3 million 1.7 million -

TRAW Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 57000 -
Dec. 31, 2025 - -
Sept. 30, 2025 - -
June 30, 2025 2.7 million 1000

TRAW

Price: $1.45

52 week price:
0.97
3.27

Earnings Per Share: -1.87 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 22.6 million

Links: